Use of IL-1 antagonists to treat gout and pseudogout

Details for Australian Patent Application No. 2007309470 (hide)

Owner Regeneron Pharmaceuticals, Inc.

Inventors Vicary, Catherine; Mellis, Scott

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2007309470

PCT Pub. Number WO2008/051496

Priority 60/853,385 20.10.06 US

Filing date 19 October 2007

Wipo publication date 2 May 2008

International Classifications

A61K 38/17 (2006.01) Medicinal preparations containing peptides - from animals

A61K 38/20 (2006.01) Medicinal preparations containing peptides - Interleukins

A61P 19/02 (2006.01) Drugs for skeletal disorders

A61P 19/06 (2006.01) Drugs for skeletal disorders

Event Publications

7 May 2009 PCT application entered the National Phase

  PCT publication WO2008/051496 Priority application(s): WO2008/051496

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007309475-Bedbug detection, monitoring and control techniques

2007309468-Heteroaryl compounds, compositions thereof, and use thereof as protein kinase inhibitors